High lifetime costs for type 2 diabetes

August 9, 2013 by Valerie Debenedette
High lifetime costs for type 2 diabetes

A person with type 2 diabetes may spend an average of nearly $85,500 to treat the disease and its complications over his or her lifetime, reports a new study in the American Journal of Preventive Medicine. The earlier diabetes is diagnosed, the greater the lifetime costs, with costs for women slightly higher than for men. Anything that can prevent or delay the onset of type 2 diabetes could lead to a sizeable reduction in healthcare costs in the future, say the researchers.

The goals of the study were to understand the financial return on preventing or delaying onset of and to get a sense of the long-term financial impact of new cases of diabetes and its complications, said Xiaohui Zhuo, Ph.D., of the Centers for Disease Control and Prevention in Atlanta and lead author. "This has become increasingly important given the rapid increase of the number of the incident cases in the U.S. and worldwide," he said.

Researchers at the CDC and Research Triangle International in Research Triangle Park, NC, created a to examine the costs of treating type 2 diabetes and its complications in newly diagnosed people over a lifetime, instead of merely focusing on the of treating type 2 diabetes in a given year.

The model revealed that a man diagnosed with type 2 diabetes between the ages of 25 and 44 can be expected to incur related costs of $124,700 over his lifetime. A woman diagnosed at the same age may incur related costs of $130,800 over her lifetime. Lifetime costs go down the later in life the diagnosis is made.

Treating complications due to diabetes account for 53 percent of lifetime costs, with 57 percent of that due to complications caused by damage to large blood vessels, which can lead to and stroke.

Direct medical costs include both the costs of treating diabetes, such as doctor visits, medication, and testing supplies, and for treating complications such as , , eye damage, heart disease, amputations, and stroke.

"This is a different approach to a calculation of the costs of diabetes," said Robert E. Ratner, M.D., chief scientific and medical officer at the American Diabetes Association. "A better way of doing it is to note that in 2012, in the U.S., we actually had $176 billion in direct medical costs treating people with diabetes," he said. "This is up 40 percent in five years."

Ratner noted that complications due to diabetes have been decreasing in incidence and severity because of better control of blood sugar levels. "There has been a 50 percent reduction in the need for amputations and a 35 percent drop in kidney disease requiring dialysis or transplantation in the last 12 years," he said. But these gains—and their associated cost reductions—are swamped by the rising number of new cases of type 2 diabetes. "When you look at the annual costs, you can clearly see this is an untenable rate of growth."

Explore further: Cost of diabetes care in US keeps climbing

More information: Zhuo X, Zhang P, Hoerger TJ. (2013), Lifetime direct medical costs of treating type 2 diabetes and diabetic complications, American Journal of Preventive Medicine.

Related Stories

Cost of diabetes care in US keeps climbing

March 6, 2013
(HealthDay)—The total cost of diabetes in the United States jumped from $174 billion in 2007 to $245 billion in 2012, a new report shows.

Study shows US diabetes care improves, potential gaps remain

April 25, 2013
(Medical Xpress)—According to a recent study published in the New England Journal of Medicine, Americans with diabetes had increasingly better control of their blood sugar and cholesterol levels and attended more preventive ...

One in eight Americans diagnosed with type 2 diabetes, poll says

February 20, 2013
(HealthDay)—A staggering one in eight Americans has been diagnosed with type 2 diabetes, a new Harris Interactive/HealthDay poll suggests.

Rise in type 2 diabetes amongst young

May 20, 2013
The number of young people diagnosed with type 2 diabetes has seen the sharpest rise over the last twenty years compared to a background of a general increase across the board, new University research has found.

Long-time diabetics have increased risk of stroke

March 1, 2012
The longer you have diabetes, the higher your risk for stroke, according to a study in Stroke, an American Heart Association journal.

Meeting dual HbA1c and LDL-C goals improves diabetes care

July 9, 2013
(HealthDay)—Dual achievement of both glycated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDL-C) goals among patients with diabetes is associated with greater clinical and economic benefit than achievement ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.